Serum Endocan Levels in Patients with Psoriasis Vulgaris as a Marker of Disease Severity | ||
Zagazig University Medical Journal | ||
Article 19, Volume 26, Issue 3, May 2020, Pages 517-523 PDF (1.05 M) | ||
Document Type: Original Article | ||
DOI: 10.21608/zumj.2019.13587.1252 | ||
Authors | ||
Ibrahim Elgharib1; Naglaa Khalifa2; Ola Elasser1; Mohamed ElGhareeb3; Doaa Hosny* 4 | ||
1Dermatology,venereology&Andrology Department,Faculty of Medicine,Zagazig University,Zagazig,Egypt | ||
2Department of Clinical Pathology,Faculty of Medicine,Zagazig University,Zagazig, Egypt | ||
3Dermatology,Venereology&Andrology Department, Faculty of Medicine, Zagazig University,Zagazig,Egypt | ||
4Dermatology, Venereology & Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. | ||
Abstract | ||
ABSTRACT Background: Endocan is a specific molecule of human endothelial cell. It was accepted as a marker of endothelial dysfunction that is widely involved in psoriasis development. Our aim was to evaluate the relation between serum endocan levels and severity of psoriasis vulgaris . Methods: Twenty-two patients with psoriasis vulgaris were involved . We measured serum endocan, c-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Psoriasis severity was evaluated by Psoriasis Area and Severity Index (PASI) score. Results: The mean serum level of endocan was 154±49.3 pg/ml with a range from 59 to 210 pg/ml. Its level was statistically significant increase in moderate and severe psoriatic patients compared to mild psoriatic patients. No statistically significant correlations were detected between serum endocan and CRP (P=0.11) and ESR(P=0.16). In contrast, a very highly statistically significant positive correlation was detected between endocan and disease severity(p=0.001). Conclusions: Serum endocan can be a promising marker that correlates with psoriasis vulgaris severity. | ||
Keywords | ||
endocan; Psoriasis; endothelial dysfunction | ||
Statistics Article View: 531 PDF Download: 570 |